Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. (KPTI) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 738 transactions totaling $180.3M, demonstrating a bearish sentiment with -$159.7M in net insider flow. The most recent transaction on Jan 21, 2026 involved a sale of 265 shares valued at $1.6K.
KPTI Insider Activity Summary
Who Is Buying KPTI Stock?
No significant insider buying has been recorded for KPTI in the recent period.
Who Is Selling KPTI Stock?
No significant insider selling has been recorded for KPTI in the recent period.
Is Karyopharm Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KPTI is bearish with an Insider Alignment Score of 6/100 and a net flow of -$159.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KPTI Frequently Asked Questions
Understanding KPTI Insider Activity
Insider trading at Karyopharm Therapeutics Inc. (KPTI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading KPTI stock, having executed 738 transactions in the past 90 days. The most active insider is Marcin Czernik (Executive), who has made 35 transactions totaling $30.6M.
Related Tools
Track Karyopharm Therapeutics Inc. Insider Activity
Get notified when executives and directors at KPTI file new Form 4 transactions